- Home
- RXST vs INVA Comparison
RXST vs INVA Comparison
Compare RXST & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXST
- INVA
- Stock Information
- Founded
- RXST 1997
- INVA 1996
- Country
- RXST United States
- INVA United States
- Employees
- RXST N/A
- INVA N/A
- Industry
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- INVA Biotechnology: Pharmaceutical Preparations
- Sector
- RXST Health Care
- INVA Health Care
- Exchange
- RXST Nasdaq
- INVA Nasdaq
- Market Cap
- RXST 1.2B
- INVA 1.1B
- IPO Year
- RXST 2021
- INVA 2004
- Fundamental
- Price
- RXST $29.60
- INVA $18.08
- Analyst Decision
- RXST Strong Buy
- INVA Buy
- Analyst Count
- RXST 8
- INVA 1
- Target Price
- RXST $58.13
- INVA N/A
- AVG Volume (30 Days)
- RXST 492.3K
- INVA 436.3K
- Earning Date
- RXST 02-25-2025
- INVA 03-07-2025
- Dividend Yield
- RXST N/A
- INVA N/A
- EPS Growth
- RXST N/A
- INVA 46.55
- EPS
- RXST N/A
- INVA 0.99
- Revenue
- RXST $128,293,000.00
- INVA $352,745,000.00
- Revenue This Year
- RXST $60.30
- INVA $16.20
- Revenue Next Year
- RXST $34.65
- INVA N/A
- P/E Ratio
- RXST N/A
- INVA $18.25
- Revenue Growth
- RXST 67.52
- INVA 21.46
- 52 Week Low
- RXST $26.29
- INVA $14.33
- 52 Week High
- RXST $66.54
- INVA $21.28
- Technical
- Relative Strength Index (RSI)
- RXST 33.54
- INVA 45.13
- Support Level
- RXST $29.65
- INVA $17.92
- Resistance Level
- RXST $32.25
- INVA $18.20
- Average True Range (ATR)
- RXST 1.25
- INVA 0.26
- MACD
- RXST -0.14
- INVA -0.04
- Stochastic Oscillator
- RXST 4.66
- INVA 33.33
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The Company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.